Exchange: OTC·Updated 12:13 PM EDT

RVPH Reviva Pharmaceuticals Holdings Inc.

$0.5415
$0.0015
(0.28%)
Today
Reported EarningsAug 12
Mkt Cap$7.08M
Vol14,006.00

About RVPH

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
61

Bullish Sentiment

How do you feel about RVPH?

Advertisement|Remove ads.